✦ LIBER ✦

Safety and efficacy of infliximab therapy in active behcet’s uveitis: an open-label trial

✍ Scribed by H. Al-Rayes; R. Al-Swailem; M. Al-Balawi; N. Al-Dohayan; S. Al-Zaidi; M. Tariq

Book ID: 106007587
Publisher: Springer
Year: 2008
Tongue: English
Weight: 272 KB
Volume: 29
Category: Article
ISSN: 0172-8172
DOI: 10.1007/s00296-008-0606-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of infliximab in the treatment

Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in behçet's disease: An open-label trial

✍ Ilknur Tugal-Tutkun; Abdulbaki Mudun; Meri Urgancioglu; Sevil Kamali; Esen Kasap 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 2 views

Safety and efficacy of maintenance infli

Safety and efficacy of maintenance infliximab therapy for moderate-to-severe Crohn’s disease in children: REACH open-label extension

✍ Hyams, Jeffrey; Walters, Thomas D.; Crandall, Wallace; Kugathasan, Subra; Griffi 📂 Article 📅 2011 🏛 Informa plc 🌐 English ⚖ 296 KB

Efficacy and safety of infliximab vs. me

Efficacy and safety of infliximab vs. methotrexate in patients with moderate-to-severe plaque psoriasis: results of an open-label, active-controlled, randomized trial (RESTORE1)

✍ J. Barker; M. Hoffmann; G. Wozel; J.-P. Ortonne; H. Zheng; H. van Hoogstraten; K 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 346 KB

Evaluation of the efficacy and safety of

Evaluation of the efficacy and safety of infliximab on psoriatic nails: an unblinded, nonrandomized, open-label study

✍ D. Rigopoulos; S. Gregoriou; A. Stratigos; G. Larios; C. Korfitis; D. Papaioanno 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 219 KB

Efficacy of infliximab in pediatric Croh

Efficacy of infliximab in pediatric Crohn's disease: A randomized multicenter open-label trial comparing scheduled to on demand maintenance therapy

✍ Frank M. Ruemmele; Alain Lachaux; Jean-Pierre Cézard; Alain Morali; Chantal Maur 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB 👁 2 views

## Background: Infliximab (ifx) is efficacious in inducing remission in severe forms of pediatric crohn's disease (cd). adult studies indicate that ifx is also safe and well tolerated as maintenance therapy. the present study aimed to evaluate in a prospective manner the efficacy and safety of ifx

Efficacy and safety of short-term adalim

Efficacy and safety of short-term adalimumab treatment in patients with active Crohn's disease who lost response or showed intolerance to infliximab: a prospective, open-label, multicentre trial

✍ J. HINOJOSA; F. GOMOLLÓN; S. GARCÍA; G. BASTIDA; J. L. CABRIADA; C. SARO; D. CEB 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 557 KB